Effect of depressive symptoms and HIV exposure on the quality of life of HIV-seropositive and seronegative pregnant women
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFRGS |
Texto Completo: | http://hdl.handle.net/10183/216462 |
Resumo: | Introduction: Depression among human immunodeficiency virus (HIV)-seropositive individuals has been associated with reduced quality of life. Objective: To evaluate the effect of depressive symptoms and HIV exposure on mean quality of life scores in HIV-seropositive and HIV-seronegative postpartum women. Methods: A cross-sectional study was conducted with two groups: 80 HIV-seropositive and 80 HIV-seronegative postpartum women. The Edinburgh Postnatal Depression Scale and the World Health Organization Quality of Life short-version scale were used to assess presence of depressive symptoms and quality of life scores. Two-way analysis of variance was used to compare the effects of depressive symptoms, HIV exposure and interaction between depressive symptoms and HIV exposure on mean quality of life scores, with p < 0.05 considered statistically significant. Results: Depressive symptoms were present in 35% (28) of HIV-seropositive and 17.5% (14) of HIV-seronegative participants (p = 0.02). The interaction between depressive symptoms and HIV exposure was not significant for any quality of life domain. The main effect of HIV exposure was also not significant. Depressive symptoms had a negative influence on quality of life scores in all domains (physical health, psychological health, social relationships and environment) (p < 0.001). Conclusion: The quality of life of pregnant women is negatively influenced by the presence of depressive symptoms. |
id |
UFRGS-2_dd74f13fd65b967cae7c54bbd76d3fd7 |
---|---|
oai_identifier_str |
oai:www.lume.ufrgs.br:10183/216462 |
network_acronym_str |
UFRGS-2 |
network_name_str |
Repositório Institucional da UFRGS |
repository_id_str |
|
spelling |
Zoche, EsterBosa, Vera LúciaChaves, Eunice Beatriz MartinCapp, EdisonCorleta, Helena von Eye2020-12-11T04:13:47Z20192357-9730http://hdl.handle.net/10183/216462001118496Introduction: Depression among human immunodeficiency virus (HIV)-seropositive individuals has been associated with reduced quality of life. Objective: To evaluate the effect of depressive symptoms and HIV exposure on mean quality of life scores in HIV-seropositive and HIV-seronegative postpartum women. Methods: A cross-sectional study was conducted with two groups: 80 HIV-seropositive and 80 HIV-seronegative postpartum women. The Edinburgh Postnatal Depression Scale and the World Health Organization Quality of Life short-version scale were used to assess presence of depressive symptoms and quality of life scores. Two-way analysis of variance was used to compare the effects of depressive symptoms, HIV exposure and interaction between depressive symptoms and HIV exposure on mean quality of life scores, with p < 0.05 considered statistically significant. Results: Depressive symptoms were present in 35% (28) of HIV-seropositive and 17.5% (14) of HIV-seronegative participants (p = 0.02). The interaction between depressive symptoms and HIV exposure was not significant for any quality of life domain. The main effect of HIV exposure was also not significant. Depressive symptoms had a negative influence on quality of life scores in all domains (physical health, psychological health, social relationships and environment) (p < 0.001). Conclusion: The quality of life of pregnant women is negatively influenced by the presence of depressive symptoms.application/pdfengClinical and biomedical research. Vol. 39, n. 2 (2019), p. 116-121GravidezQualidade de vidaHIVDepressãoPregnancyQuality of lifeDepressionEffect of depressive symptoms and HIV exposure on the quality of life of HIV-seropositive and seronegative pregnant womeninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/otherinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRGSinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSTEXT001118496.pdf.txt001118496.pdf.txtExtracted Texttext/plain27742http://www.lume.ufrgs.br/bitstream/10183/216462/2/001118496.pdf.txt4c06dc1bd13048bf181013c2c04f18d8MD52ORIGINAL001118496.pdfTexto completo (inglês)application/pdf773830http://www.lume.ufrgs.br/bitstream/10183/216462/1/001118496.pdf05d4027337067cfa72f911b95bd58634MD5110183/2164622020-12-12 05:21:43.907176oai:www.lume.ufrgs.br:10183/216462Repositório de PublicaçõesPUBhttps://lume.ufrgs.br/oai/requestopendoar:2020-12-12T07:21:43Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.pt_BR.fl_str_mv |
Effect of depressive symptoms and HIV exposure on the quality of life of HIV-seropositive and seronegative pregnant women |
title |
Effect of depressive symptoms and HIV exposure on the quality of life of HIV-seropositive and seronegative pregnant women |
spellingShingle |
Effect of depressive symptoms and HIV exposure on the quality of life of HIV-seropositive and seronegative pregnant women Zoche, Ester Gravidez Qualidade de vida HIV Depressão Pregnancy Quality of life Depression |
title_short |
Effect of depressive symptoms and HIV exposure on the quality of life of HIV-seropositive and seronegative pregnant women |
title_full |
Effect of depressive symptoms and HIV exposure on the quality of life of HIV-seropositive and seronegative pregnant women |
title_fullStr |
Effect of depressive symptoms and HIV exposure on the quality of life of HIV-seropositive and seronegative pregnant women |
title_full_unstemmed |
Effect of depressive symptoms and HIV exposure on the quality of life of HIV-seropositive and seronegative pregnant women |
title_sort |
Effect of depressive symptoms and HIV exposure on the quality of life of HIV-seropositive and seronegative pregnant women |
author |
Zoche, Ester |
author_facet |
Zoche, Ester Bosa, Vera Lúcia Chaves, Eunice Beatriz Martin Capp, Edison Corleta, Helena von Eye |
author_role |
author |
author2 |
Bosa, Vera Lúcia Chaves, Eunice Beatriz Martin Capp, Edison Corleta, Helena von Eye |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Zoche, Ester Bosa, Vera Lúcia Chaves, Eunice Beatriz Martin Capp, Edison Corleta, Helena von Eye |
dc.subject.por.fl_str_mv |
Gravidez Qualidade de vida HIV Depressão |
topic |
Gravidez Qualidade de vida HIV Depressão Pregnancy Quality of life Depression |
dc.subject.eng.fl_str_mv |
Pregnancy Quality of life Depression |
description |
Introduction: Depression among human immunodeficiency virus (HIV)-seropositive individuals has been associated with reduced quality of life. Objective: To evaluate the effect of depressive symptoms and HIV exposure on mean quality of life scores in HIV-seropositive and HIV-seronegative postpartum women. Methods: A cross-sectional study was conducted with two groups: 80 HIV-seropositive and 80 HIV-seronegative postpartum women. The Edinburgh Postnatal Depression Scale and the World Health Organization Quality of Life short-version scale were used to assess presence of depressive symptoms and quality of life scores. Two-way analysis of variance was used to compare the effects of depressive symptoms, HIV exposure and interaction between depressive symptoms and HIV exposure on mean quality of life scores, with p < 0.05 considered statistically significant. Results: Depressive symptoms were present in 35% (28) of HIV-seropositive and 17.5% (14) of HIV-seronegative participants (p = 0.02). The interaction between depressive symptoms and HIV exposure was not significant for any quality of life domain. The main effect of HIV exposure was also not significant. Depressive symptoms had a negative influence on quality of life scores in all domains (physical health, psychological health, social relationships and environment) (p < 0.001). Conclusion: The quality of life of pregnant women is negatively influenced by the presence of depressive symptoms. |
publishDate |
2019 |
dc.date.issued.fl_str_mv |
2019 |
dc.date.accessioned.fl_str_mv |
2020-12-11T04:13:47Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/other |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10183/216462 |
dc.identifier.issn.pt_BR.fl_str_mv |
2357-9730 |
dc.identifier.nrb.pt_BR.fl_str_mv |
001118496 |
identifier_str_mv |
2357-9730 001118496 |
url |
http://hdl.handle.net/10183/216462 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartof.pt_BR.fl_str_mv |
Clinical and biomedical research. Vol. 39, n. 2 (2019), p. 116-121 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFRGS instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Repositório Institucional da UFRGS |
collection |
Repositório Institucional da UFRGS |
bitstream.url.fl_str_mv |
http://www.lume.ufrgs.br/bitstream/10183/216462/2/001118496.pdf.txt http://www.lume.ufrgs.br/bitstream/10183/216462/1/001118496.pdf |
bitstream.checksum.fl_str_mv |
4c06dc1bd13048bf181013c2c04f18d8 05d4027337067cfa72f911b95bd58634 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFRGS - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
|
_version_ |
1815447727261089792 |